Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

This article contains data on clinical endpoints (Peak Flow Expiratory Rate, fractional exhaled nitric oxide and total IgE serum levels) and plasma pharmacokinetic parameters concerning the use of the oral CRTh2 antagonist QAW039 (fevipiprant) in mild to moderate asthma patients. Information on expe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Data Brief
Main Authors: Erpenbeck, Veit J., Popov, Todor A., Miller, David, Weinstein, Steven F., Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Data Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021787/
https://ncbi.nlm.nih.gov/pubmed/27656673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2016.08.039
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados